XML 19 R3.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Operating activities:    
Net Income (Loss) $ 86,577 $ 22,117
Non-cash elements included in net income    
Depreciation, depletion and amortization 77,086 105,147
Inventory adjustments 2,370 9,896
Fair value adjustments, net (13,242) (3,150)
Provision for reclamation and closure costs 3,815 3,606
Stock-based compensation 4,923 4,146
Deferred income taxes 39,509 5,688
Net foreign exchange loss (gain) 3,873 (6,655)
Other non-cash items, net (1,544) (196)
Change in assets and liabilities:    
Accounts receivable (10,439) (17,114)
Inventories (20,821) (30,873)
Other current and non-current assets 12,691 8,342
Accounts payable, accrued and other current liabilities 3,819 (2,301)
Accrued payroll and related benefits 7,823 3,820
Accrued taxes 2,006 (1,016)
Accrued reclamation and closure costs and other non-current liabilities (912) (5,659)
Net cash provided by operating activities 197,534 95,798
Investing activities:    
Additions to property, plant and mine development (112,138) (98,009)
Proceeds from investment sales 3,696 0
Proceeds from disposition of assets 128 1,274
Purchases of investments 0 (73)
Net cash used in investing activities (108,314) (96,808)
Financing activities:    
Proceeds from sale of common stock, net 174,132 1,103
Acquisition of treasury stock (885) (1,197)
Borrowing of debt 133,000 67,000
Repayment of debt (117,000) (133,000)
Dividends paid to common and preferred stockholders (5,023) (7,994)
Repayments of finance leases and other (4,220) (5,505)
Net cash provided by (used in) financing activities 180,004 (79,593)
Effect of exchange rates on cash 479 (1,180)
Net increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents 269,703 (81,783)
Cash, cash equivalents and restricted cash and cash equivalents at beginning of period 28,045 107,539
Cash, cash equivalents and restricted cash and cash equivalents at end of period 297,748 25,756
Reconciliation of cash and cash equivalents and restricted cash and cash equivalents above    
Cash and cash equivalents 296,565 24,585
Non-current restricted cash and cash equivalents 1,183 1,171
Total cash and cash equivalents and restricted cash and cash equivalents as reported on the consolidated cash flow statement 297,748 25,756
Supplemental disclosure of cash flow information:    
Cash paid for interest 21,387 23,442
Cash paid for income and mining taxes, net 6,380 4,999
Significant non-cash investing and financing activities:    
Common stock issued as incentive compensation 2,503 3,355
Common stock issued for 401(k) match $ 2,605 $ 2,322